Health
Expert panel provides guidance for optimized design of early drug trials for Alzheimer’s, related dementias – News-Medical.Net
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best…
An expert panel convened by the Alzheimer’s Drug Discovery Foundation (ADDF) and The Association for Frontotemporal Degeneration (AFTD) provides guidance on best practices for the design of early drug trials for Alzheimer’s disease, frontotemporal degeneration (FTD), and other neurodegenerative dementias. Their guidance was published in the May 18, 2021 issue of Neurology®, the medical journal of the American Academy of Neurology (“Value-Generating Exploratory Trials in Neurodegenerative Dementias”).
…
-
General24 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General15 hours agoFirst home buyers score early access to deposit scheme
-
Noosa News14 hours agoForum responds to urgent homelessness issues in Nambour
-
General13 hours agoEnergy provider ENGIE to ‘correct’ electricity bills for thousands of South Australian customers